tiprankstipranks
CARGO Therapeutics, Inc. (CRGX)
NASDAQ:CRGX
US Market

CARGO Therapeutics, Inc. (CRGX) Income Statement

Compare
60 Followers

CARGO Therapeutics, Inc. Income Statement

Last quarter (Q3 2024), CARGO Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, CARGO Therapeutics, Inc.'s net income was $-41.91M. See CARGO Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ -3.69M$ -1.44M$ -147.00K
Operating Expenses
$ 93.02M$ 34.77M$ 5.98M
Depreciation and Amortization
$ 3.69M$ 1.44M$ 147.00K
EBITDA
$ -93.02M$ -33.35M$ -5.70M
Operating Income
$ -96.71M$ -34.77M$ -5.98M
Other Income/Expenses
$ -1.44M$ -6.18M$ 127.00K
Pretax Income
$ -98.15M$ -40.95M$ -5.85M
Net Income
$ -98.15M$ -40.95M$ -5.85M
Per Share Metrics
$ ―$ ―$ ―
Basic EPS
$ -2.38$ -2.13$ -0.30
Diluted EPS
$ -2.38$ -2.13$ -0.30
Weighted Average Shares Outstanding
41.21M 19.23M 19.47M
Weighted Average Shares Outstanding (Diluted)
41.21M 19.23M 19.47M
Currency in USD

CARGO Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis